Though President Trump denied having any connection to Project 2025 on the campaign trail, he has pushed its health policy ...

Discontinuing tyrosine kinase inhibitor maintenance after extended complete molecular response should only be attempted as part of a clinical trial, the researchers say.

A multivariate analysis confirmed the independent prognostic significance of both landmark and longitudinal MRD.